News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Which Company Outperformed All Other Biotechs in August?


9/5/2012 8:16:19 AM

Sarepta, the developer of a new muscular dystrophy drug with extremely promising results, saw its shares gain more than any other medical stock in my monthly scan of biotech, pharma, and medical device stocks. This scan, using data from Interactive Data and Thomson Reuters Fundamentals via FactSet Research Systems, includes companies that have a market capitalization of more than $300 million at the beginning or end of the period from the close on July 31 to the close on Aug. 31.

Read at Forbes


comments powered by Disqus
Forbes
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES